Several small molecules, including the MDM2 antagonist Nutlin-3a and the USP7 inhibitor P22077, have been reported to suppress tumor growth in a chemoresistant NB model by activating the p53 pathway14, 15. Here, TP53 is linked to neuroblastoma.